Novo Nordisk's Saxenda Approved But Company Enters Into A Crowded Obesity Market
December 26, 2014 at 15:58 PM EST
Saxenda Approved by the FDA to treat Obesity but faces big obstacles against many competitors.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.